Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embla Medical hfOSSFF +9.64%91 Operating Cash Flow per Share is $0.34 as of Jun. 2026. GuruFocus rates OSSFF with a GF Score™ of 91/100 and a GF Value™ of $4.85. Among 651 Medical Devices & Instruments companies, Embla Medical hf ranks better than 66.51% on this metric.
Embla Medical hf's operating cash flow per share for the
three
months ended in Jun. 2026 was $0.09.
Embla Medical hf's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.34.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Embla Medical hf was 10.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 24.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 9.00% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Embla Medical hf's Operating Cash Flow per Share or its related term are showing as below:
OSSFF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -12.2 Med: 7.5 Max: 52.5
Current: 24.7
During the past 13 years, Embla Medical hf's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.50% per year. The lowest was -12.20% per year. And the median was 7.50% per year.
OSSFF's 3-Year OCF Growth Rate is ranked better than 66.51% of 651
companies
in the Medical Devices & Instruments industry
Industry Median: 12.3
vs OSSFF: 24.70
Embla Medical hf Operating Cash Flow per Share Related Terms
Embla Medical hf Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf Operating Cash Flow per Share Chart
OSSFF vs ABT, SYK, MDT: Operating Cash Flow per Share Comparison
For the Medical Devices subindustry, Embla Medical hf's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.34
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.34 mean?
Embla Medical hf (OSSFF) has a Operating Cash Flow per Share of $0.34 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Embla Medical hf and its competitors. According to the industry distribution chart, Embla Medical hf ranks #218 out of 651 companies in the Medical Devices & Instruments industry, placing it in the top 33.5%.
Is Embla Medical hf's Operating Cash Flow per Share too high?
Embla Medical hf's current Operating Cash Flow per Share is $0.34. The Medical Devices & Instruments industry median Operating Cash Flow per Share is 12.30. Embla Medical hf's value of $0.34 is 97.2% below this industry median. Based on the distribution chart, Embla Medical hf ranks #218 out of 651 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Operating Cash Flow per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #218 out of 651 companies for Operating Cash Flow per Share. This puts Embla Medical hf in the upper half of its industry. The industry median Operating Cash Flow per Share is 12.30. Embla Medical hf's value of $0.34 is 97.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.30, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Operating Cash Flow per Share of $0.34 is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Operating Cash Flow per Share is $0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Operating Cash Flow per Share of $0.34. The stock's GF Value™ is $4.85, compared to a current price of $4.55 — trading 6.2% below its estimated fair value. The current Operating Cash Flow per Share is $0.34 and 97.2% below the Medical Devices & Instruments industry median of 12.30. Embla Medical hf's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Operating Cash Flow per Share is $0.34 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.55 is trading 6.2% below its estimated GF Value™ of $4.85.
Key valuation signals for OSSFF:
Operating Cash Flow per Share: $0.34
GF Value™: $4.85 vs. price of $4.55 (6.2% below fair value)
Industry Position: 97.2% below the Medical Devices & Instruments median (#218 of 651)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
91GF Score
Get the complete analysis for OSSFF
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
